Temporal Alterations in CD8⁺ T Cells During the Progression From Stage 1 to Stage 3 Type 1 Diabetes.

Autor: Schroderus, Anna-Mari, Pitkänen, Viola, Ekman, Ilse, Stevens, Daniella, Rytkönen-Nissinen, Marja, Rintamäki, Reeta, Pihlajamäki, Jussi, Knip, Mikael, Veijola, Riitta, Toppari, Jorma, Ilonen, Jorma, Lempainen, Johanna, Kinnunen, Tuure

Publikováno v: Diabetes; Oct2024, Vol. 73 Issue 10, p1705-1715, 11p

Temporal Alterations in CD8+ T Cells During the Progression From Stage 1 to Stage 3 Type 1 Diabetes.

Autor: Schroderus AM; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland., Pitkänen V; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland., Ekman I; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland., Stevens D; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland., Rytkönen-Nissinen M; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland., Rintamäki R; Department of Medicine, Endocrinology and Clinical Nutrition, Kuopio University Hospital, Kuopio, Finland., Pihlajamäki J; Department of Medicine, Endocrinology and Clinical Nutrition, Kuopio University Hospital, Kuopio, Finland.; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland., Knip M; Tampere Center for Child Health Research, Tampere University Hospital, Tampere, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Veijola R; Research Unit of Clinical Medicine, Department of Pediatrics, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland., Toppari J; Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.; Research Centre for Integrative Physiology and Pharmacology, InFLAMES Research Flagship, Institute of Biomedicine, University of Turku, Turku, Finland.; Centre for Population Health Research, InFLAMES Research Flagship, Institute of Biomedicine, University of Turku, Turku, Finland., Ilonen J; Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland., Lempainen J; Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.; Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland., Kinnunen T; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.; ISLAB Laboratory Centre, Kuopio, Finland.

Publikováno v: Diabetes [Diabetes] 2024 Oct 01; Vol. 73 (10), pp. 1705-1715.